|
1
|
Wilson JW: Nocardiosis: updates and
clinical overview. Mayo Clin Proc. 87:403–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosman Y, Grossman E, Keller N, Thaler M,
Eviatar T, Hoffman C and Apter S: Nocardiosis: A 15-year experience
in a tertiary medical center in Israel. Eur J Intern Med.
24:552–557. 2013.PubMed/NCBI
|
|
3
|
Cattaneo C, Antoniazzi F, Caira M,
Castagnola C, Delia M, Tumbarello M, et al: Nocardia spp
infections among hematological patients: results of a retrospective
multicenter study. Int J Infect Dis. 17:e610–614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garcia-Bellmunt L, Sibila O, Solanes I,
Sanchez-Reus F and Plaza V: Pulmonary nocardiosis in patients with
COPD: characteristics and prognostic factors. Arch Bronconeumol.
48:280–285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambrosioni J, Lew D and Garbino J:
Nocardiosis: updated clinical review and experience at a tertiary
center. Infection. 38:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mootsikapun P, Intarapoka B and
Liawnoraset W: Nocardiosis in Srinagarind Hospital, Thailand:
review of 70 cases from 1996–2001. Int J Infect Dis. 9:154–158.
2005.
|
|
7
|
Saubolle MA and Sussland D: Nocardiosis:
review of clinical and laboratory experience. J Clin Microbiol.
41:4497–4501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castro JG and Espinoza L: Nocardia
species infections in a large county hospital in Miami: 6 years
experience. J Infec. 54:358–361. 2007.PubMed/NCBI
|
|
9
|
Tuo MH, Tsai YH, Tseng HK, Wang WS, Liu CP
and Lee CM: Clinical experiences of pulmonary and bloodstream
nocardiosis in two tertiary care hospitals in northern Taiwan,
2000–2004. J Microbiol Immunol Infect. 41:130–136. 2008.PubMed/NCBI
|
|
10
|
Zhao K, Dong MJ, Sheng ZK, Liu KF, Yang
SY, Liu ZF and Sheng JF: Elevated uptake of 18F-FDG in
PET/CT imaging of a nocardial pleural nodule. Clin Imaging.
36:383–385. 2012.
|
|
11
|
Hannaman MJ and Ertl MJ: Patients with
immunodeficiency. Med Clin North Am. 97:1139–1159. 2013. View Article : Google Scholar
|
|
12
|
Matulionyte R, Rohner P, Uckay I, Lew D
and Garbino J: Secular trends of nocardia infection over 15 years
in a tertiary care hospital. J Clin Pathol. 57:807–812.
2004.PubMed/NCBI
|
|
13
|
Martínez Tomás R, Menéndez Villanueva R,
Reyes Calzada S, Santos Durantez M, Vallés Tarazona JM, Modesto
Alapont M and Gobernado Serrano M: Pulmonary nocardiosis: risk
factors and outcomes. Respirology. 12:394–400. 2007.
|
|
14
|
Uhde KB, Pathak S, McCullum I Jr,
Jannat-Khah DP, Shadomy SV, Dykewicz CA, et al:
Antimicrobial-resistant Nocardia isolates, United States,
1995–2004. Clin Infect Dis. 51:1445–1448. 2010.PubMed/NCBI
|
|
15
|
Tremblay J, Thibert L, Alarie I,
Valiquette L and Pépin J: Nocardiosis in Quebec, Canada, 1988–2008.
Clin Microbiol Infect. 17:690–696. 2011.
|
|
16
|
Brown-Elliott BA, Biehle J, Conville PS,
Cohen S, Saubolle M, Sussland D, et al: Sulfonamide resistance in
isolates of Nocardia spp. from a US multicenter survey. J
Clin Microbiol. 50:670–672. 2012.
|
|
17
|
Lai CC, Liu WL, Ko WC, Chen YH, Tan HR,
Huang YT and Hsueh PR: Multicenter study in Taiwan of the in vitro
activities of nemonoxacin, tigecycline, doripenem, and other
antimicrobial agents against clinical isolates of various
Nocardia species. Antimicrob Agents Chemother. 55:2084–2091.
2011. View Article : Google Scholar
|
|
18
|
Garcia del Palacio JI and Martín Pérez I:
Response of pulmonary nocardiosis to ceftriaxone in a patient with
AIDS. Chest. 103:1925–1926. 1993.PubMed/NCBI
|
|
19
|
Lo W and Rolston KV: Use of imipenem in
the treatment of pulmonary nocardiosis. Chest. 103:951–952. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fihman V, Berçot B, Mateo J, Losser MR,
Raskine L, Riahi J, et al: First successful treatment of
Nocardia farcinica brain abscess with moxifloxacin. J
Infect. 52:e99–e102. 2006.
|
|
21
|
Tanioka K, Nagao M, Yamamoto M, Matsumura
Y, Tabu H, Matsushima A, et al: Disseminated Nocardia
farcinica infection in a patient with myasthenia gravis
successfully treated by linezolid: a case report and literature
review. J Infect Chemother. 18:390–394. 2012.
|
|
22
|
Ogawa T, Kasahara K, Yonekawa S, Nakagawa
C, Maeda K, Konishi M, et al: Nocardia beijingensis
pulmonary infection successfully treated with intravenous β-lactam
antibiotics and oral minocycline. J Infect Chemother. 17:706–709.
2011. View Article : Google Scholar
|
|
23
|
Lewis KE, Ebden P, Wooster SL, Rees J and
Harrison GA: Multi-system infection with Nocardia
farcinica-therapy with linezolid and minocycline. J Infect.
46:199–202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen Q, Zhou H, Li H and Zhou J: Linezolid
combined with trimethoprim-sulfamethoxazole therapy for the
treatment of disseminated nocardiosis. J Med Microbiol.
60:1043–1045. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu X, Han F, Wu J, He Q, Peng W, Wang Y,
et al: Nocardia infection in kidney transplant recipients:
case report and analysis of 66 published cases. Transpl Infect Dis.
13:385–391. 2011. View Article : Google Scholar
|
|
26
|
Shen T, Wu L, Geng L, Wei Z and Zheng S:
Successful treatment of pulmonary Nocardia farcinica
infection with linezolid: case report and literature review. Braz J
Infect Dis. 15:486–489. 2011.
|
